Science Translational Medicine

Science Translational Medicine
source
Title	Science Translational Medicine
Discipline	Interdisciplinary research, Biomedical engineering, Medicine
Language	English
Editor	American Association for the Advancement of Science
Publisher	American Association for the Advancement of Science

Contents

Science Translational Medicine is a leading international Peer-reviewed journal that focuses on Translational research, aiming to facilitate the transformation of Basic science discoveries into Clinical practice. The journal publishes original research articles, reviews, and Editorials from renowned experts in the field, including National Institutes of Health researchers, Harvard University faculty, and Stanford University scholars. By bridging the gap between Laboratory findings and Clinical trials, Science Translational Medicine contributes to the development of innovative therapies and diagnostic tools, as seen in the work of Francis Collins, Eric Lander, and David Baltimore. The journal's interdisciplinary approach involves collaborations with University of California, Berkeley, Massachusetts Institute of Technology, and University of Oxford.

Introduction

Science Translational Medicine introduces a new paradigm in scientific publishing, emphasizing the importance of Collaboration between Basic science researchers, clinical researchers, and Industry experts, such as those from Pfizer, Merck & Co., and GlaxoSmithKline. This approach is reflected in the journal's editorial board, which comprises distinguished scientists from California Institute of Technology, University of Cambridge, and Columbia University. By facilitating the exchange of ideas and expertise, the journal accelerates the translation of scientific discoveries into Medical practice, as demonstrated by the work of Anthony Fauci, Elizabeth Blackburn, and James Watson. Science Translational Medicine also provides a platform for discussing the Ethics and Policy implications of emerging technologies, such as Gene editing and Stem cell research, with input from World Health Organization, National Academy of Sciences, and European Union.

The concept of Science Translational Medicine emerged from the recognition that Basic science discoveries often fail to translate into Clinical practice, a challenge addressed by National Cancer Institute, National Institute of Mental Health, and National Institute of Neurological Disorders and Stroke. In response, the American Association for the Advancement of Science launched the journal in 2009, with the goal of creating a forum for Interdisciplinary research and Collaboration, involving institutions like University of California, Los Angeles, University of Michigan, and Duke University. Since its inception, Science Translational Medicine has published numerous groundbreaking studies, including those on Cancer research, Neuroscience, and Infectious disease, with contributions from Centers for Disease Control and Prevention, World Health Organization, and Bill and Melinda Gates Foundation.

The scope of Science Translational Medicine encompasses a broad range of topics, including Biomedical engineering, Gene therapy, and Regenerative medicine, with applications in Cardiovascular disease, Neurodegenerative disease, and Infectious disease, as studied by researchers at University of California, San Francisco, Johns Hopkins University, and University of Pennsylvania. The journal focuses on the development of innovative therapies and diagnostic tools, as well as the Translation of Basic science discoveries into Clinical practice, with collaborations between Industry partners, such as Biogen, Gilead Sciences, and Regeneron Pharmaceuticals, and academic institutions like Harvard University, Stanford University, and Massachusetts Institute of Technology. By emphasizing the importance of Collaboration and Interdisciplinary research, Science Translational Medicine aims to accelerate the development of effective treatments for Diseases, as seen in the work of National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, and National Institute of Environmental Health Sciences.

The publication process of Science Translational Medicine involves a rigorous Peer review system, ensuring that only high-quality research articles are published, with input from Editorial boards at University of California, Berkeley, California Institute of Technology, and Columbia University. The journal's editorial team, comprising experts from National Institutes of Health, Harvard University, and Stanford University, works closely with authors to ensure that manuscripts meet the journal's high standards, as demonstrated by the work of Eric Kandel, David Julius, and Huda Zoghbi. Science Translational Medicine also offers a range of article types, including research articles, reviews, and Editorials, providing a platform for scientists to share their findings and perspectives, with contributions from University of Oxford, University of Cambridge, and Imperial College London.

Science Translational Medicine has had a significant impact on the scientific community, with its articles being widely cited and influencing research in Biomedical engineering, Medicine, and Public health, as seen in the work of Centers for Disease Control and Prevention, World Health Organization, and National Academy of Sciences. The journal's emphasis on Collaboration and Interdisciplinary research has inspired new approaches to Medical research, as demonstrated by the work of Francis Collins, Eric Lander, and David Baltimore. Science Translational Medicine has also played a key role in shaping Policy and Regulation in the field of Biotechnology, with input from Food and Drug Administration, European Medicines Agency, and National Institute of Standards and Technology.

Current research and applications in Science Translational Medicine include the development of innovative therapies for Cancer, Neurodegenerative disease, and Infectious disease, as studied by researchers at University of California, San Francisco, Johns Hopkins University, and University of Pennsylvania. The journal has also featured research on Gene editing, Stem cell therapy, and Regenerative medicine, with applications in Cardiovascular disease, Neurological disorder, and Musculoskeletal disease, with contributions from National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute of Neurological Disorders and Stroke, and National Institute of Child Health and Human Development. By highlighting the latest advances in Translational research, Science Translational Medicine continues to inspire new discoveries and innovations, with collaborations between Industry partners, such as Pfizer, Merck & Co., and GlaxoSmithKline, and academic institutions like Harvard University, Stanford University, and Massachusetts Institute of Technology. Category:Scientific journals